跳至主要内容
临床试验/CTRI/2018/11/016258
CTRI/2018/11/016258尚未招募不适用

A possible case of Etoricoxib- Induced Fixed Drug Eruption

Dr Apoorva1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2018年6月11日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
1
试验地点
1
主要终点
Adverse drug reaction due to etoricoxib

研究概览

简要总结

A  Case of Fixed Drug Eruption due to Etoricoxib in a 50yr old male patient

Dr Apoorva, Dr Girish K, Dr Namritha C Manjunath

Kempegowda Institute of Medical Sciences & Research Center (KIMS& RC), Bangalore,Karnataka,India

BACKGROUND/OBJECTIVES

Fixed drug eruption  is a commonly reported adverse drug reaction.Non-steroidal anti inflammatory drugs(NSAIDs)  in particular nimesulide are the most frequent agents, followed by antibiotics and anticonvulsants. Etoricoxib is a  selective cyclo-oxygenase  isoenzyme 2 inhibitor which has rarely been  a cause of Fixed Drug Eruption.

We present a case of fixed drug eruption due to Etoricoxib in a 50yr old male patient with previous allergic history to NSAIDs.

CASE REPORT/METHODS:

50yr old male patient was prescribed Tab Etoricoxib by local doctor for low backpain.Next day  the patient noticed reddish raised lesion, with pain and itching which was initially seen  on the neck and gradually progressed to both the limbs and trunk. Subsequently, the patient  was admitted to KIMS Hospital. A diagnosis of Fixed Drug Eruption due to Etoricoxib was made after ruling out other causes. Treatment was initiated with Intravenous and topical Steroids and  IV Ceftriaxone was given for seconday infection. The lesions improved significantly with the above management and the patient was discharged after a week of admission.

RESULTS:

The reaction was assessed to be“probable†as per WHO-UMC and Naranjo causality scale, “moderateâ€on Hartwig’s scale and “Probably  preventable†according to Schumock and Thornton criteria.

CONCLUSION:

Reactions such as Fixed Drug Eruptions can be caused by drugs like Etoricoxib.

研究设计

研究类型
Observational

入排标准

年龄范围
50.00 Year(s) 至 51.00 Year(s)(—)
性别
Male

入选标准

  • 50 yr old male patient with complain of fixed drug eruption due to tab Etoricoxib.

排除标准

  • 未提供

结局指标

主要结局

Adverse drug reaction due to etoricoxib

时间窗: within 24 hrs

次要结局

未报告次要终点

研究者

发起方
Dr Apoorva
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验

尚未招募
不适用
Reddish skin rash caused by pain medication Etoricoxib
CTRI/2018/11/016258Dr Apoorva
进行中(未招募)
不适用
Die perioperative Anwendung von Etoricoxib verglichen mit Diclofenac bei Patienten nach Implantation einer Hüftgelenkstotalendoprothese, prospektive, doppelt blinde Phase IIIb Studie - ARCOXIAMedDRA version: 12.1Level: LLTClassification code 10048793Term: CoxarthrosisIn this clinical trial we will investigate patients who suffer from primary or secondary coxarthrosis where an implantation of a total hip joint endoprosthesis is indicated. It will be analyzed whether the use of Etoricoxib as compared to Diclofenac leads to a reduction of the perioperative risk of bleedings.
EUCTR2009-015383-33-DEFreistaat Bayern, vertreten durch die Universität Regensburg
尚未招募
Unknown
To study the role of an additive to pregabalin for pain relief in patients posted for total abdominal hysterectomy under regional anaesthesia .
CTRI/2023/05/053127sardar patel medical college, bikaner
已完成
4 期
Prevention of Heterotopic Ossification With Arcoxia After Total Hip ReplacementOssification, Heterotopic
NCT01022190Radboud University Medical Center42
进行中(未招募)
不适用
Evaluación de la respuesta a etoricoxib en pacientes con Espondilitis Anquilosante (EA) e inadecuada respuesta > o = a 2 AINESEspondilitis AnquilosanteMedDRA version: 9Level: PTClassification code 10002556Term: Ankylosing spondylitis
EUCTR2009-017309-12-ESFUNDACIÓN ESPAÑOLA DE REUMATOLOGÍA (FER)